Sunday, November 22, 2009
Print Current Day:
|
|
SESSION 39 SCHEDULE | |
Sunday
SESSION 39:
NEW DEVELOPMENTS, TECHNIQUES AND CONCEPTS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
6:45 AM - 6:50 AM | What Proportion Of AAAs Can Be Treated With Current Endografts? |
6:51 AM - 6:56 AM | Use Of Duplex Imaging To Detect Common Femoral Artery Injuries During EVAR |
6:57 AM - 7:02 AM | Tips And Tricks In The Endovascular Treatment Of Large A-V Fistulas |
7:03 AM - 7:08 AM | Virtual Angioscopy Of The Thoracic And Abdominal Aorta: Is It A Useful Tool Or A Fancy Toy? |
7:09 AM - 7:14 AM | Tips And Tricks To Make TIPS Procedures Effective Using Stent-Grafts |
7:15 AM - 7:20 AM | How To Use Clopidigrel (Plavix) To Make CEA Safer |
7:21 AM - 7:26 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
7:26 AM - 7:31 AM | Myths And Little Known Facts About Collateral Development With Major Arterial Occlusion |
7:32 AM - 7:37 AM | Minimally Invasive Approach To Treat The Median Arcuate Ligament Syndrome: Technique And Results |
7:38 AM - 7:43 AM | Chronic Lymphedema: How Best To Treat It: Are There Still Surgical Options? |
7:44 AM - 7:49 AM | Technical Tips For Crossing Long Tibial Occlusions |
7:50 AM - 7:55 AM | Are Reentry Devices Necessary When Crossing Most Long Totally Occluded Segments? |
7:56 AM - 8:01 AM | New Developments And Updated Results With Duplex Guided PTA And Stenting |
8:02 AM - 8:08 AM | Panel Discussion |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Sunday
SESSION 40:
MORE ABOUT THORACIC AND ABDOMINAL ANEURYSMS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
8:08 AM - 8:13 AM | 10-Year Results After EVAR vs. 10-Year Results After Open Repair |
8:14 AM - 8:19 AM | Updated Data On Safety Of Bilateral Hypogastric Interruption With EVAR And OR: Cooperative Study In 135 Patients |
8:20 AM - 8:25 AM | Endovascular Treatment Of Iliac Aneurysms Involving The Hypogastric Artery: Concurrent Comparison Of Branched Endografts vs. Hypogastric Occlusion |
8:26 AM - 8:31 AM | Significance Of Mesenteric Arteries During EVAR |
8:32 AM - 8:37 AM | Debate 21: With EVAR Outcomes Are Not Influenced By AAA Size |
8:38 AM - 8:43 AM | Debate 21: With EVAR Outcomes Are Influenced By Size: Big Is Bad |
8:44 AM - 8:49 AM | Can Positron Emission Tomography (PET) Imaging And Biochemical Analysis Help To Predict AAA Rupture? |
8:50 AM - 8:56 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
8:56 AM - 9:01 AM | Technique For Fascial Suture To Close Puncture Sites For Percutaneously Placed Large Sheaths: It Works But It Has To Be Done Right (Video Presentation) |
9:02 AM - 9:07 AM | Tips And Tricks For Improving Results Or Managing Tortuous Or Adverse Neck Anatomy With The Gore Excluder Graft |
9:08 AM - 9:13 AM | New Developments In The Management Of Graft Enteric (Aortoduodenal) Fistulas: Successful In Situ Repair With Silver Impregnated, Rifampin Soaked Grafts |
9:14 AM - 9:19 AM | Advantages And Limitations Of The New Medtronic Valiant Captivia Stent-Graft For TEVAR |
Presenters(s):Matt M. Thompson, MD | |
9:20 AM - 9:25 AM | Adjuvant Maneuvers To Affect Graft Tilt During EVAR With Angulated Necks: Should We Try To Fit The Aorta To The Graft Or Should We Try To Fit The Graft To The Aorta – And How? |
9:26 AM - 9:31 AM | Off-The-Shelf Device For EVAR Treatment Of Juxtarenal Aneurysms |
9:32 AM - 9:38 AM | Panel Discussion |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Sunday
SESSION 41:
NEW DEVELOPMENTS IN DISEASES OF THE CAROTIDS, VERTEBRALS AND SUPRA-AORTIC TRUNKS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
9:38 AM - 9:43 AM | Debate 22: Covered Stents Are Good For The Treatment Of Carotid Artery Aneurysms |
9:44 AM - 9:49 AM | Debate 22: Endovascular Repair Of Extracranial Carotid Aneurysms Is Still A Hazardous Procedure |
9:50 AM - 9:55 AM | Mortality And Cost Implications For Delaying Treatment After A TIA Or Small Stroke Are Serious: How To Facilitate Early Treatment: The EXPRESS Trial |
9:56 AM - 10:01 AM | Determinants And Late Clinical Significance Of Microemboli With CAS And CEA: When Do They Matter? |
10:02 AM - 10:07 AM | Dos And Don’ts Of Endovascular Management Of Carotid Trauma |
10:07 AM - 10:20 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
10:20 AM - 10:25 AM | Routine Shunting vs. Selective Shunting In CEA Based On Stump Pressure: Which Is Best Based On A Randomized Controlled Trial? |
10:26 AM - 10:31 AM | New Portable Multisensor Transducer For Carotid Screening By Non-Specialized Office Personnel |
10:32 AM - 10:37 AM | Update On Population Based Studies Comparing Adverse Event Rates With CAS And CEA In The U.S.: Are CAS Results Improving? |
10:38 AM - 10:43 AM | Diagnosis And Treatment Of Vulnerable Carotid Plaques Causing TIAs Or Strokes: When Should They Be Treated By CEA Or By CAS? |
10:44 AM - 10:49 AM | Tips And Tricks For The Endovascular Treatment Of Subclavian And Innominate Stenosis |
10:50 AM - 10:55 AM | Update On Treatment Of Acute Stroke By IV Thrombolysis And CEA: Why CEA Not CAS: Advantages And Limitations |
10:56 AM - 11:03 AM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Sunday
SESSION 42:
NEW DEVELOPMENTS IN CAS (4-MINUTE FAST PACED TALKS)
xxxx
Moderators:TBD
|
|
x | |
11:03 AM - 11:07 AM | What The Trial And Registry Results To Date Tell Us About The Present Status Of CAS: What Are The Prospects For A Change In This Status In The Future? |
11:08 AM - 11:12 AM | How To Lower Risk Of CAS In Octogenerians And Other High Risk Patients |
11:13 AM - 11:17 AM | Combined Carotid And Coronary Procedures: Nationwide Statistics Show That CAS Has Lower Adverse Events Rates Than CEA |
11:18 AM - 11:22 AM | CAS Experience With Endovascular Flow Interruption Using The MOMA Device: Advantages And Limitations |
11:23 AM - 11:27 AM | Use Of IVUS As An Important Quality Control Technique For CAS: Are There Risks To Its Use? |
11:28 AM - 11:32 AM | Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is Worthwhile So It Can Be Treated By CAS Or CEA |
11:33 AM - 11:37 AM | Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is A Bad Thing To Do Except As A Way To Get Patients On Statins: CAS Or CEA In Asymptomatic Patients Consumes Resources But Does Little To Prevent Stroke |
11:38 AM - 11:42 AM | Carotid Interventions For Stroke In Evolution: Indications, Techniques And Results: A 5-Year Experience |
11:43 AM - 11:47 AM | CAS Setbacks: The Plan Was Flawed From The Beginning: Will CAS Recover? |
11:48 AM - 11:52 AM | Carotid Stenting For Radiation Arteritis Has A High Complication And Restenosis Rate |
11:53 AM - 11:59 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
11:59 AM - 12:03 PM | Clinical Course Of Asymptomatic Carotid Stenosis With End-Diastolic Velocity 100-125 cm/sec: Stent Or Observe? |
12:04 PM - 12:08 PM | Technique Of Using An Interruption Of Flow Embolic Protection Device (MOMA) To Make CAS Safer |
12:09 PM - 12:13 PM | How To Identify Stroke Threatening Plaques In Asymptomatic Patients By Contrast Duplex Or Biochemical Markers (Alpha NT pro BNP) |
12:14 PM - 12:18 PM | The Value Of Pre-Procedure CTA To Improve The Outcomes Of CAS |
12:19 PM - 12:23 PM | Restenosis After CAS Is Equal To That After CEA Based On Long-Term Results In 1,000 Patients |
12:24 PM - 12:28 PM | Transcervical CAS With Flow Reversal Eliminates Emboli During CAS: Why Does It Work And What Are The Adverse Event Rates With This Approach? |
12:29 PM - 12:33 PM | Outcomes After CEA: Is There A High Risk Population And Does This Have A Bearing On Some Of The CAS Trials Such As SAPPHIRE? |
Presenters(s):Richard P. Cambria, MD | |
12:34 PM - 12:45 PM | Panel Discussion Refreshments Available |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Sunday
SESSION 43:
NEW CONCEPTS, ADVANCES, LATE BREAKING INFORMATION (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
12:45 PM - 12:50 PM | Debate 24: Transcranial Doppler During CAS: When And Why Is Flow Reversal With The Gore-Parodi Device Better? |
12:51 PM - 12:56 PM | Debate 24: Why Flow Cessation During CAS (With The MOMA Device) Is Better: The ARMOUR Trial |
12:57 PM - 1:02 PM | Update On Results From The ACT Trial Comparing CEA And CAS With Protection In Asymptomatic Patients With Carotid Stenosis |
1:03 PM - 1:08 PM | Tips And Tricks To Allow Large Sheath Access For TEVAR And EVAR: Alternatives To External Conduits When Iliac Arteries Are Too Small Or Diseased To Allow Femoral Access |
1:09 PM - 1:14 PM | Noninvasive Treatment For CLI With A Sequential Compression Device: Does It Work? |
1:15 PM - 1:20 PM | What Are The Results And Complications With The TAG Endograft When It Is Used More Widely And Not Only In Centers Of Excellence (The Post Marketing Approval Trial)? |
1:21 PM - 1:26 PM | Treatment Of Iliac Aneurysms By Off-Label Modified Use Of Reversed ZENITH Limb Extensions: Technical Tips |
1:27 PM - 1:32 PM | What Is The Value Of C-Arm CT Scanning In EVAR Procedures And Patients? |
Presenters(s):Matt M. Thompson, MD | |
1:33 PM - 1:38 PM | The NELLIX Sac Anchoring Endoprosthesis For AAA Exclusion: A New Concept For EVAR |
1:39 PM - 1:44 PM | Advantages To 3-D Imaging (With M2S, TeraRecon, Or 3-Mensio) In Planning For Standard Infrarenal EVAR Procedures |
1:45 PM - 1:53 PM | Panel Discussion |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Sunday
SESSION 44:
NEW CONCEPTS, ADVANCES AND LATE BREAKING INFORMATION (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
1:53 PM - 1:58 PM | New Developments In The Treatment Of Fibromuscular Dysplasia |
1:59 PM - 2:04 PM | When To Stent Renal Artery Stenosis With EVAR And What To Do For Restenosis |
2:05 PM - 2:10 PM | HYPERMED Camera For Measuring Cutaneous O2 Saturation Before And After Intervention: How Does It Help? |
2:11 PM - 2:16 PM | Cutting Balloon Facilitates CAS With Very Calcified Plaques: What Are The Dangers? |
2:17 PM - 2:22 PM | CAS Is Appropriate In Asymptomatic Patients But Not In Symptomatic Patients: CMS Has It Wrong |
2:23 PM - 2:28 PM | Endografts Can Serve As A Bridge To Definitive Repair: When And How Can This Be Helpful? |
2:29 PM - 2:34 PM | Lower Extremity Arterial Flow Is Decreased In Patients With Venous Disease: Why Does It Matter? |
2:35 PM - 2:40 PM | EVAR Without Contrast Is Safe: How To Do It |
2:41 PM - 2:46 PM | Covered Stents Will Improve Treatment For Renal Artery Stenosis |
2:47 PM - 2:52 PM | Cerebral Hyperfusion Syndrome Is Not What You Think: We Have Been Misled |
2:53 PM - 3:00 PM | Panel Discussion |
3:00 PM - 3:05 PM | Raffle Prize Drawing for fully paid, clinician attendees. You must be present to win. |
3:05 PM - 3:05 PM | Symposium Ends |
END OF SESSION 44 |